Citation Impact
4 standout
Citing Papers
The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation
2024 Standout
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
2024 Standout
Works of Mohit Mathur being referenced
MO258SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF VIS649, AN APRIL-NEUTRALIZING IGG2 MONOCLONAL ANTIBODY, IN HEALTHY VOLUNTEERS: PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE ASCENDING DOSE STUDY
2021
Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
2019
Author Peers
| Author | Nephrology | Epidemiology | Hematology | Rheumatology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Mohit Mathur | 166 | 116 | 54 | 61 | 37 | 307 | |
| S. Geetha | 31 | 321 | |||||
| Hope A. Flaxman | 12 | 38 | 10 | 261 | |||
| M Lenziardi | 8 | 15 | 1 | 7 | 10 | 328 | |
| David Rodrick | 7 | 2 | 1 | 23 | 235 | ||
| Kazimierz Dąbrowski | 2 | 15 | 350 |
All Works
Loading papers...